Biocon gets 4 USFDA observations for Bengaluru facility Ruchika Sharma30 Sept 2024 6:45 PM ISTBangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...
Biocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region Ruchika Sharma27 Sept 2024 11:30 AM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the signing of a licensing and supply agreement with Tabuk...
USFDA concludes inspection at Biocon Bengaluru API facility Ruchika Sharma23 Sept 2024 12:06 PM ISTBangalore: Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded a surveillance inspection at the Company's...
Biocon arm gets USFDA nod for chronic heart failure drug Sacubitril/Valsartan Ruchika Sharma2 Sept 2024 11:27 AM ISTBangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval of its...
Biocon gets USFDA EIR for Visakhapatnam API facility Ruchika Sharma6 Aug 2024 11:33 AM ISTBangalore: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities Ruchika Sharma29 July 2024 12:53 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...
USFDA inspection: Biocon gets 4 observations for Visakhapatnam API facility Ruchika Sharma24 Jun 2024 2:15 PM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded a GMP inspection of the...
Biocon arm receives EMA approval to manufacture biosimilar Bevacizumab at Bengaluru facility Ruchika Sharma24 Jun 2024 12:15 PM ISTBengaluru: Biocon Biologics Ltd, a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
USFDA issues 3 observations for Biocon Visakhapatnam API facility Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel Ruchika Sharma13 Jun 2024 4:09 PM ISTBangalore: Biocon has announced the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key...
Biocon gets USFDA nod for antifungal medication Micafungin Ruchika Sharma4 Jun 2024 2:51 PM ISTBengaluru: Biocon Limited has received approval from the U.S. Food and Drug Administration (US FDA), for its vertically integrated, complex...
